H16.233
Neurotrophic keratoconjunctivitis, bilateral
Clinical Classification Guidelines
Medical Intelligence & Overview
Neurotrophic keratoconjunctivitis, bilateral, is a rare eye condition characterized by decreased corneal sensitivity and impaired healing of the corneal surface in both eyes. This condition can lead to ongoing damage, persistent ulcers, and in severe cases, vision loss if not managed properly. It involves nerve damage to the cornea, which interferes with the eye's ability to heal and defend itself against injury or infections.
Causes & Symptoms
Clinical Causes: Trauma or injury to the trigeminal nerve or corneal nerves Neurodegenerative diseases such as herpes zoster ophthalmicus or herpes simplex virus Diabetic neuropathy affecting ocular nerves Surgical procedures involving the eye, including cataract or corneal surgeries Chemical burns or prolonged use of topical medications Systemic diseases that impact nerve health
Key Symptoms: Reduced or lost corneal sensation (numbness in the eye) Persistent or recurrent corneal epithelial defects Corneal ulcers that resist healing Eye redness and discomfort Blurred or decreased vision Tearing or dryness of the affected eyes Difficulty detecting injuries or foreign objects on the cornea
Diagnostic & Treatment
Diagnosis Path: Diagnosis of neurotrophic keratoconjunctivitis involves a comprehensive eye examination, including testing corneal sensitivity typically with a cotton wisp or esthesiometer. Additional assessments may include slit-lamp examination to evaluate corneal damage, fluorescein staining to identify epithelial defects, and testing for underlying causes such as nerve damage or systemic conditions. In some cases, tear function tests or imaging studies may help identify associated factors or complications.
Treatment Protocols: Management focuses on promoting corneal healing, protecting the ocular surface, and addressing underlying causes. Treatment options may include: - Use of preservative-free artificial tears and lubricants to maintain moisture and comfort - Application of topical medications to promote epithelial healing, such as growth factors or nerve growth promoters - Use of protective measures like bandage contact lenses or amniotic membrane transplantation - Antibiotic ointments or drops to prevent infection in areas of epithelial loss - Minimizing trauma by avoiding eye rubbing and exposure to irritants - Addressing systemic conditions contributing to nerve damage - Surgical interventions, including corneal neurotization or nerve regeneration techniques, in severe or refractory cases - Regular follow-up with ophthalmologists to monitor healing progress and prevent complications
Clinical Advice & FAQs
Billing Guidance
Is H16.233 a billable ICD-10 code?
Yes, H16.233 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H16.233?
Clinical documentation must specify the nature of Neurotrophic keratoconjunctivitis, bilateral and any associated comorbidities for accurate reporting.
Cite this Clinical Reference